The Alliance

Spotlight Series

The Alliance Spotlight Series is a recurring one-page publication for front-line healthcare professionals, offering quick-takes on critical topics affecting the field of organ donation and transplantation. We encourage you to download these issues and share them with your front-line colleagues and partners.

Spotlight Series Past Issues

Exclusive Access

Take advantage of our 2023 professional partnership levels of support to receive exclusive early access to The Alliance Insight Series publications.

You’ll still have access to all our materials when they go online one month after publication.

Volume VIII ,
Issue 5
TechInnovation 360x240
A critical phase during the process is the transportation and preservation of an organ from the donor to the recipient. With improved preservation and perfusion, increased preservation time and transportation distances are permitted, and early data is demonstrating improved outcomes.

Keeping Up with Technical Innovations in Organ Transplantation: Perfusion and Preservation Technology (Part 1)

Clarifying terminology:

Perfusion Terminology

Advances in organ preservation and perfusion techniques and technologies are demonstrating improved organ transplant outcomes and increased organ utilization from deceased organ donors, especially from those with complex medical history or older ages.

A critical phase during the process is the transportation and preservation of an organ from the donor to the recipient. With improved preservation and perfusion, increased preservation time and transportation distances are permitted, and early data is demonstrating improved outcomes.

Presently, organs traveling between the donor and the recipient are maintained mostly in static cold storage (SCS). Chilled preservation solutions that contain ingredients to prevent cellular swelling and help to minimize molecular changes within the cells are utilized along with wet ice to maintain storage temperature between 4-8 °C (Hosgood et al. 2021). There are however side effects to this type of storage, primarily, cell swelling, acidosis and ischemic/reperfusion injury, which can cause early graft dysfunction and can contribute to chronic complications in the recipient.

In recent years, several different preservation advances have emerged in the transplantation field to help limit some of the negative effects of cold storage, extend preservation times for organs, as well as to facilitate the use of medically complex or at-risk organs.

Determining which technique and technology to utilize for a particular donor, organ or situation, still requires more experience and outcome data.

Types of preservation and perfusion technologies:

In principle, there are currently three perfusion / preservation technologies:

  1. Hypothermic machine perfusion (HMP) / Hypothermic oxygenated machine perfusion (HOPE)
    Description: A dynamic, oxygenated cold preservation method at 4°C which supplies oxygen to the graft (organ) during the ex vivo period.
  1. Normothermic machine perfusion (NMP)
    Description: An ex vivo preservation of organs at normal body temperatures with the help of a machine that also provides oxygen and nutrients.
  1. Normothermic regional perfusion (NRP)
    Description: An in situ (or in vivo) perfusion of a portion (region) of the donor’s body with the help of extracorporeal organ support (ECOS), utilized in donation after circulatory determination of death (DCD) donors immediately following cessation of cardiac function. This supplies the organs with blood and oxygen during the organ-recovery process.

Which organs would benefit and in what way?

All of these technologies and approaches to organ preservation and perfusion are still being extensively and actively researched to determine best use and outcomes for various organs. New data and identification of outcome benefits are frequently published and thus, information is rapidly increasing. Early results are suggesting an increased use of organs, particularly from DCD donors, as well as a reduction in ischemic reperfusion injury, early allograft dysfunction, ischemic type biliary lesions, delayed graft function, cold ischemic times, as well as potentially restorative possibilities and improved assessment opportunities of the various organs. It is recommended to closely follow publications on this topic to remain current with the developments (some examples are listed in the reference section).

Who is responsible for storing, managing, and transporting these devices and the needed supplies?

This is a question that is still being discussed and varies across the country. In some instances, the organ procurement organization (OPO) may assume this role, in some locations the transplant center will, and in other areas a Regional Perfusion Center (a dedicated location with the technologies to providing perfusion and preservation services) may provide this service. Additionally, there are significant costs and resource commitments to provide this service which still need to be evaluated and managed.

Keeping our eyes on stewardship

In the meantime, the mission of organ donation and transplantation is too vital, the stewardship of these gifts too precious and the time remaining for those waiting for their transplant too unpredictable, for the donation and transplantation community of practice not to embrace innovation and advances in preservation and perfusion technology.

Helpful Resources


National Critical Issues Forum Presentation (2022): Navigating Technical Innovation: Access, Product Selection and Value. Kevin Myer, Dr. Victor Pretorius, Dr. Garrett Roll.

OPTN Glossary –

Van Rijn R, et al. 2021. Hypothermic Machine Perfusion in Liver Transplantation – A Randomized Trial. New England Journal of Medicine. 2021; 384(15): 1391-1401. doi: 10.1056/NEJMoa2031532

Langmuur SJJ, et al. 2022. Normothermic ex situ heart perfusion with the organ care system for cardiac transplantation: A meta-analysis. Transplantation. 2022; 106(9): 1745-1753. doi: 10.1097/TP.0000000000004167

Hamelink T, et al. 2022. Renal Normothermic Machine Perfusion: The Road Toward Clinical Implementation of a Promising Pretransplant Organ Assessment Tool. Transplantation. 2022; 106(2): 268-279. doi: 10.1097/TP.0000000000003817

Holm AM, et al. 2022. ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD). The Journal of Heart and Lung Transplantation. 2022; 41(6): 671-677.

Hosgood SA, et al. 2021. Advances in kidney preservation techniques and their application in clinical practice. Transplantation. 2021; 105(11): e202-e214. doi: 10.1097/TP.0000000000003679

Tingle SJ, et al. 2020. Hypthermic machine perfusion is superior to static cold storage in deceased donor kidney transplantation: A meta-analysis. Clinical Transplantation. 2020; 24(4):e13814. doi: 10.1111/ctr.13814

Loor G. 2018. EVLP: Ready for Prime Time? Seminars in Thoracic and Cardiovascular Surgery. 2018; 31(1): 1-6.

Qin G, et al. 2022. Machine perfusion for human heart preservation: A systematic review. Transplant International. 2022; 35 (Article 10258): 1-9. doi: 10.3389/ti.2022.10258

Hunt F, et al. 2022. From haphazard to a sustainable normothermic regional perfusion service: a blueprint for the introduction of novel perfusion technologies. Transplant International. 2022; 3(35): 10493. doi: 10.3389/ti.2022.10493. eCollection 2022

Questions & Comments

Please send all questions and/or feedback to [email protected].


Worth Sharing
Volume VIII, Issue 5

A Special Thanks to This Series’ Contributors

Hedi Aguiar
Hedi Aguiar
Program Consultant
Organ Donation and Transplantation Alliance
Deanna Fenton
About the Editor |
Deanna Fenton

Deanna is a knowledgeable and versatile professional with diverse experiences in healthcare, client relations, marketing, project management and demonstrated skills in leadership and advocacy. Prior to joining The Alliance, she worked in Hospital Development at her local OPO in the state of New Jersey where she served as the clinical liaison to a number of Level 1 Trauma & Neuroscience centers as well as community hospitals. Her personal connection as a donor family and friend fuels her passion to support her colleagues across the donation-transplantation continuum through the development of valuable educational resources that ultimately boost performance and improve outcome measures. Deanna holds a Bachelor of Arts in Psychology and a minor degree in Public Health from Montclair State University. In her spare time, Deanna enjoys visiting vineyards, spending time with her family, and traveling in hopes of visiting all seven wonders of the world.

Advancing All.

The Alliance is not a membership organization and therefore relies on annual voluntary financial support from OPOs and transplant programs who find value in our programs and initiatives.

We invite you to join us as a professional partner